Trials / Completed
CompletedNCT03486964
Use of Incretins in Diabetic Patients
Observational Study on the Use of Incretins in Diabetic Patients: Evaluation of Metabolic Effects and Cardiovascular Events
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,234 (actual)
- Sponsor
- University of Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Observational, retrospective study, conducted in diabetic patients aimed to evaluate the effects on the glyco-metabolic control and on cardiovascular events of different DPP-4 inhibitors. Patients will be stratified in patients taking different DPP-4 in addition to sulfonylureas, biguanides, thiazolidinediones, insulin, compared to those in therapy with other hypoglycemic classes, such as sulphonylureas, biguanides, thiazolidinediones, insulin, alone or in combination, in primary and secondary prevention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DPP-4 inhibitors | Patients will be retrospectively evaluated after the addition of a DPP-4 inhibitor to previously taken anti-diabetic therapy |
Timeline
- Start date
- 2018-03-27
- Primary completion
- 2020-12-31
- Completion
- 2021-05-30
- First posted
- 2018-04-03
- Last updated
- 2022-05-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03486964. Inclusion in this directory is not an endorsement.